Angiotensin News and Research

RSS

Angiotensin is an oligopeptide in the blood that causes vasoconstriction, increased blood pressure, and release of aldosterone from the adrenal cortex. It is a powerful dipsogen. It is derived from the precursor molecule angiotensinogen, a serum globulin produced in the liver. It plays an important role in the renin-angiotensin system.

The changing face of the COVID-19 epidemic

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus, which hit China with the disease now named COVID-19 in December 2019 and has since spread to over 70 countries, has caused over 90,000 cases, and 3,117 fatalities, with 95% or more of both being in China.

2 Mar 2020

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, today announced the launch of a Pilot investigator-initiated clinical trial with APN01, a recombinant human angiotensin-converting enzyme 2, to treat patients with severe coronavirus infection in the People's Republic of China.

26 Feb 2020

Advancing a protein drug in lettuce leaves to treat pulmonary arterial hypertension

In pulmonary arterial hypertension, high blood pressure in the lungs' arteries causes the heart to work extra hard to pump blood to the lungs and around the rest of the body.

16 Feb 2020

Study finds link between meditation, the endocrine system, health and wellbeing

New collaborative research at Queen's University Belfast and Victoria University, Melbourne, Australia aims to better understand the link between meditation and improved mental health outcomes.

12 Feb 2020

Burnout linked to higher risk for abnormal heart rhythm

A new study published in January 2020 in the European Journal of Preventive Cardiology shows that burnout could really cause your heart to fail as a result of an abnormal heart rhythm called atrial fibrillation (AF).

14 Jan 2020

Long-term consumption of lingonberry juice lowers high blood pressure, study finds

An experimental study found that long-term consumption of lingonberry juice lowers high blood pressure and improves the function of blood vessels.

3 Jan 2020

FDA checks metformin drugs for potentially carcinogenic substance

The FDA is checking metformin medications used to treat diabetes for a potential carcinogen, N-nitrosodimethylamine (NDMA).

11 Dec 2019

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Cancer patients receiving common heart drugs have less heart damage from cancer therapy, according to research presented today at EuroEcho 2019, a scientific congress of the European Society of Cardiology.

4 Dec 2019

Large gap between norms and actual quality of primary care in Canadian kidney patients

Chronic kidney disease (CKD) is a condition commonly encountered in primary health care the world over. However, a new study published in JAMA Network on September 4, 2019, shows that the standard of primary care is quite variable.

26 Oct 2019

Study compares safety and effectiveness of first-line antihypertensive drug classes

For those with extremely high blood pressure, or hypertension, there are many initial medication options -- so many that it can be hard to know which one to use.

25 Oct 2019

First-line antihypertensives may not be most effective, study shows

Thiazide diuretics demonstrate better effectiveness and cause fewer side effects than ACE inhibitors as first-line antihypertensive drugs, according to a report published Oct. 24 in The Lancet.

25 Oct 2019

Most popular first-line treatment for hypertension may be less effective than alternative drugs

A new multinational study shows that the most popular first-line treatment for hypertension is less effective and has more side effects than an alternative that's prescribed much less often.

25 Oct 2019

Father’s nutritional pattern affects child’s cardiovascular health

While couples often change their lifestyle in order to conceive faster, including crash diets, a new study in mice throws up the possibility that this kind of extreme dietary modification by the father might result in adverse effects on the child conceived in this manner.

17 Oct 2019

Rapamycin is more effective at slowing down aging, says researcher

The scientist discusses several reasons, including fear of the actual and fictional side effects of rapamycin, everolimus and other clinically-approved drugs, arguing that no real side effects preclude their use as anti-aging drugs today.

17 Oct 2019

New drug Aliskiren shows promise for heart failure patients

A study published in the International Journal of Molecular Sciences, as part of a special issue “Heart Failure: From Molecular Basis to Therapy”, in August 2019, shows that aliskiren, a drug approved by the US Food and Drug Administration (FDA), can improve survival for over 5 years, on average, and enhance life quality in patients who have been correctly diagnosed with heart failure.

9 Oct 2019

Heart failure medication often prescribed in lower dosages than recommended

Important medication for the treatment of heart failure are often prescribed in lower dosages than recommended by international guidelines.

1 Oct 2019

FDA warns about Ranitidine containing known carcinogen NDMA

The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.

26 Sep 2019

Physiologists, researchers to discuss factors underlying cardiovascular disease at APS conference

International physiologists and researchers studying the kidney, high blood pressure and related medical conditions will convene next week at the American Physiological Society (APS) Aldosterone and ENaC in Health and Disease: The Kidney and Beyond Conference in Estes Park, Colo.

25 Sep 2019

Diabetes drug can also be used to treat heart failure

Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.

19 Sep 2019

New polypill cheaper, better at reducing cardiovascular disease

A new study from Beth Israel Deaconess Medical Center (BIDMC) has proved the cost-effectiveness and life-saving potential of the “polypill”: a single new pill which combines four commonly prescribed cardiovascular drugs into one to prevent a recurrent stroke or heart event in adult patients in low- and middle-income countries (LMIC).

5 Sep 2019

Angiotensin News and Research

Further Reading

The changing face of the COVID-19 epidemic

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

Advancing a protein drug in lettuce leaves to treat pulmonary arterial hypertension

Study finds link between meditation, the endocrine system, health and wellbeing

Burnout linked to higher risk for abnormal heart rhythm

Long-term consumption of lingonberry juice lowers high blood pressure, study finds

FDA checks metformin drugs for potentially carcinogenic substance

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Large gap between norms and actual quality of primary care in Canadian kidney patients

Study compares safety and effectiveness of first-line antihypertensive drug classes

First-line antihypertensives may not be most effective, study shows

Most popular first-line treatment for hypertension may be less effective than alternative drugs

Father’s nutritional pattern affects child’s cardiovascular health

Rapamycin is more effective at slowing down aging, says researcher

New drug Aliskiren shows promise for heart failure patients

Heart failure medication often prescribed in lower dosages than recommended

FDA warns about Ranitidine containing known carcinogen NDMA

Physiologists, researchers to discuss factors underlying cardiovascular disease at APS conference

Diabetes drug can also be used to treat heart failure

New polypill cheaper, better at reducing cardiovascular disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News